skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines pemigatinibQuestion & answer

pemigatinib · Medicine question

Which enzyme predominantly metabolises pemigatinib in vitro?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Pemigatinib is predominantly metabolised by CYP3A4 in vitro.

Sources for this answer

Pemazyre 4.5 mg - tabletsIncyte Biosciences UK Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 6Document updated 2 November 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

pemigatinib

Read the wider context, including uses, precautions and the sources behind this medicine guide.

More questions about pemigatinib

Are there any special disposal requirements for Pemazyre (pemigatinib) 4.5 mg tablets?Do Pemazyre (pemigatinib) 4.5 mg tablets require any special storage conditions?How can pemigatinib affect digoxin exposure and toxicity?How does itraconazole affect pemigatinib exposure?How does rifampicin affect pemigatinib exposure?Is hair loss a common adverse effect of pemigatinib?

Read the pemigatinib guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX